SCHEMBL29566917

SCHEMBL29566917

CCc1c(Oc2cccc(N3CCN(C)CC3)c2Cl)nc(NS(=O)(=O)c2cnn(C)c2)nc1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 7/20 0.38
▸ DRD2 P14416 3/20 0.38
▸ HTR2A P28223 2/20 0.38
▸ DRD4 P21917 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ HTR7 P34969 6/20 0.38
▸ HTR6 P50406 5/20 0.36
▸ BRD4 O60885 1/20 0.35
▸ BRPF1 P55201 1/20 0.35
▸ BRD9 Q9H8M2 1/20 0.35
▸ PAK1 Q13153 4/20 0.34
▸ MCOLN2 Q8IZK6 1/20 0.34
▸ MCOLN3 Q8TDD5 1/20 0.34
▸ MCOLN1 Q9GZU1 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ EGFR P00533 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310061 1.00 HTR1A (0.38) HTR1ADRD2HTR2ADRD4HTR2C
SCHEMBL26811557 0.94 HTR1A (0.37) HTR1ADRD2HTR2ADRD4HTR2C
SCHEMBL26811575 0.93 ACVR1 (0.37) HTR1ADRD2HTR2ADRD4HTR2C
SCHEMBL29566593 0.92 DRD2 (0.36) HTR1ADRD2HTR2ADRD4HTR2C
SCHEMBL24309884 0.92 DRD2 (0.36) HTR1ADRD2HTR2ADRD4HTR2C
SCHEMBL29567132 0.91 HTR1A (0.36) HTR1ADRD2HTR2ADRD4HTR2C
SCHEMBL26811591 0.91 HTR6 (0.38) HTR1ADRD2HTR2ADRD4HTR2C
SCHEMBL24310080 0.91 HTR1A (0.36) HTR1ADRD2HTR2ADRD4HTR2C
SCHEMBL26811618 0.91 DRD2 (0.35) HTR1ADRD2HTR2ADRD4HTR2C
SCHEMBL24309483 0.90 HTR1A (0.41) HTR1ADRD2HTR2ADRD4HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback